ArgáMedtech
@ArgaMedtech
Followers
21
Following
2
Media
6
Statuses
18
Developing the Next generation of PFA for Cardiac Ablation
Lausanne, Switzerland
Joined April 2022
We are pleased to share that we closed a €54M oversubscribed Series B raise to advance our innovative Pulsed Field Ablation technology for treating #atrialfibrillation in the US and EU. Learn more in our press release:
argamedtech.com
Pulsed Field Ablation Innovator Argá Medtech Announces €54 Million Oversubscribed Series B Capital Raise
0
0
0
Argá Medtech to present its CSE PFA platform at Stanford Biodesing New Arrhythmia technologies https://t.co/UeXc4siN4I
argamedtech.com
2023 Stanford Biodesign New Arrhythmia Technologies Retreat | Stanford Ticket Office (stanfordtickets.org)
0
0
1
Excited to share our poster presentation on Coherent Sine Burst Electroporation's first 5 patient case studies and 60-day follow-up at the AF Symposium in Boston. #AFSymposium2023 #Arga #ArgaMedtech
0
1
2
News from #JPM2023! Raised €10 Mil & achieved first-in-human in just 20 months with our Coherent Sine Burst Electroporation (#CSE) System for atrial fibrillation (#Afib) patients. ➡️ More by @MDDIonline with CEO David Neale:
0
0
1
Congrats to our CEO David Neale for being one of the 30 #innovators to watch in 2022 - according to @Dsiliconreview. 🎙Learn more about #Arga in this Q&A with David: https://t.co/gVcbkKtcd2 💡Full list of innovators at: https://t.co/1kuD4WWmd5
#Arga #Medtech #Startups
0
0
4
Thank you @holoniq for featuring us among the 200 most promising European #HealthTech #startups. 👉 Read more in the report and meet our fellow nominees at: https://t.co/GWsMKH6F74
#Arga #Medtech #Innovation #Europe
0
0
2
Thank you @MedTechOutlook for electing us as one of the top 10 #MedTech #startups in #Europe! Atrial Fibrillation affects 33M + people worldwide, and treatments have a long-term success of 50-70%. Argá's technology addresses this issue. ➡️ More on
0
0
2
We are excited to participate in @lsintelligence #Medtech Summit, an incredible opportunity to connect with other innovators and world-class investors. 📍 Check out our David Neale, CEO & Co-Founder presentation on Sept. 23 at 3 pm BST #LSIEurope22 #MedicalDevices #Cardiology
0
1
3
Atrial fibrillation is the most common irregular #heartbeat type and can lead to stroke or heart failure (@MayoClinic). @ArgaMedtech developed a #CSE pulsed field ablation catheter, soon to start EU first-in-human #trial, to improve existing treatments🫀 ✍️ ⬇️ @Medtech_Insight
1
1
4
Argá Medtech to present at LSI Emerging Medtech Euorpe 2022 https://t.co/yZcvpSx3O9
0
2
1
